Translational Medicine

FDA Helping to Usher in a New Era of Personalized Medicine - February, 2014

In a recent, detailed report, the US Food and Drug Administration (FDA) has outlined its approach for regulating new personalized therapies and devices. The report captures the broad context of what's happening in science and medicine today and the role of the FDA as we enter an era of personalized medicine, with products tailored toward specific patient subtypes, rather than broad diagnostic groups. Please read this important and relevant report, which clearly delineates the extent to which science and technology are advancing personalized medicine and influencing the way the agency does business.

20 years in pharma R&D navigation